...
首页> 外文期刊>Oncogene >Proteasome inhibitors induce nucleolar aggregation of proteasome target proteins and polyadenylated RNA by altering ubiquitin availability
【24h】

Proteasome inhibitors induce nucleolar aggregation of proteasome target proteins and polyadenylated RNA by altering ubiquitin availability

机译:蛋白酶体抑制剂通过改变泛素的可用性诱导蛋白酶体靶蛋白和聚腺苷酸化RNA的核仁聚集。

获取原文
           

摘要

The ubiquitin鈥損roteasome pathway is essential for most cellular processes, including protein quality control, cell cycle, transcription, signaling, protein transport, DNA repair and stress responses. Hampered proteasome activity leads to the accumulation of polyubiquitylated proteins, endoplastic reticulum (ER) stress and even cell death. The ability of chemical proteasome inhibitors (PIs) to induce apoptosis is utilized in cancer therapy. During PI treatment, misfolded proteins accrue to cytoplasmic aggresomes. The formation of aggresome-like structures in the nucleus has remained obscure. We identify here a nucleolus-associated RNA-protein aggregate (NoA) formed by the inhibition of proteasome activity in mammalian cells. The aggregate forms within the nucleolus and is dependent on nucleolar integrity, yet is a separate structure, lacking nucleolar marker proteins, ribosomal RNA (rRNA) and rRNA synthesis activity. The NoAs contain polyadenylated RNA, conjugated ubiquitin and numerous nucleoplasmic proteasome target proteins. Several of these are key factors in oncogenesis, including transcription factors p53 and retinoblastoma protein (Rb), several cell cycle-regulating cyclins and cyclin-dependent kinases (CDKs), and stress response kinases ataxia-telangiectasia mutated (ATM) and Chk1. The aggregate formation depends on ubiquitin availability, as shown by modulating the levels of ubiquitin and deubiquitinases. Furthermore, inhibition of chromosome region maintenance 1 protein homolog (CRM1) export pathway aggravates the formation of NoAs. Taken together, we identify here a novel nuclear stress body, which forms upon proteasome inactivity within the nucleolus and is detectable in mammalian cell lines and in human tissue. These findings show that the nucleolus controls protein and RNA surveillance and export by the ubiquitin pathway in a previously unidentified manner, and provide mechanistic insight into the cellular effects of PIs.
机译:泛素蛋白酶体途径对于大多数细胞过程至关重要,包括蛋白质质量控​​制,细胞周期,转录,信号传导,蛋白质转运,DNA修复和应激反应。蛋白酶体活性受阻会导致多泛素化蛋白的积累,内质网应激甚至细胞死亡。化学蛋白酶体抑制剂(PIs)诱导凋亡的能力被用于癌症治疗。在PI处理期间,错误折叠的蛋白质会积聚到细胞质聚集体中。在细胞核中聚集体样结构的形成仍然不清楚。我们在这里确定了通过抑制哺乳动物细胞中蛋白酶体活性形成的与核仁相关的RNA-蛋白质聚集体(NoA)。聚集体在核仁中形成并取决于核仁的完整性,但仍是一个独立的结构,缺乏核仁标记蛋白,核糖体RNA(rRNA)和rRNA的合成活性。 NoAs包含聚腺苷酸化的RNA,缀合的泛素和许多核质蛋白酶体靶蛋白。其中一些是肿瘤发生的关键因素,包括转录因子p53和视网膜母细胞瘤蛋白(Rb),几种细胞周期调控细胞周期蛋白和细胞周期蛋白依赖性激酶(CDK),以及应激反应激酶共济失调-毛细血管扩张突变(ATM)和Chk1。聚集体的形成取决于泛素的可用性,如调节泛素和去泛素酶的水平所显示的。此外,抑制染色体区域维持1蛋白同源物(CRM1)出口途径加剧了NoAs的形成。两者合计,我们在这里鉴定出一种新型的核应激体,其在核仁内因蛋白酶体的失活而形成,并且可以在哺乳动物细胞系和人体组织中检测到。这些发现表明,核仁以以前未知的方式控制蛋白质和RNA的监测以及通过遍在蛋白途径的输出,并提供了对PI的细胞作用的机械观察。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号